干扰质母细胞瘤恶性电路:可塑性陷,突触阻塞和骨髓细胞重编程
Hong Sheng Cheng1, Carol Tang2,3, Nguan Soon Tan1,4
1Lee Kong Chian School of Medicine, Nanyang Technological University Singapore.
Current opinion in clinical nutrition and metabolic care
|January 8, 2026
概括
质母细胞瘤 (GBM) 通过遗传变化和劫持神经回路来适应,导致治疗耐药性. 准酶依赖,神经回路和髓状细胞提供了一种改善GBM结果的策略.
科学领域:
- 神经瘤学神经瘤学
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 质母细胞瘤 (GBM) 由于其适应性,瘤内异质性和免疫抑制微环境而构成重大治疗挑战.
- 介质性GBM亚型与治疗耐药性和不良预后有关,突出显示了对亚型相关疗法的需要.
研究的目的:
- 审查了解GBM的适应机制的最新进展.
- 为了确定可处理的瘤性依赖,开发多轴治疗策略.
主要方法:
- 对GBM异质性,可塑性和微环境的最新研究进行分析.
- 专注于基因变化,如染色体外DNA (ecDNA) 和途径依赖性.
主要成果:
- GBM利用ecDNA和结构变异来增强耐治疗的间酶体状态,涉及p38 MAPK和STAT3等途径.
- 瘤细胞共同选择神经元活动和神经调节输入,导致突触丰富区域的免疫抑制.
- 骨髓系衍生因素和突触重塑有助于GBM生长,介质细胞过渡和免疫逃避.
结论:
- GBM的弹性源于表观遗传的可塑性,神经电路的选择性和骨髓驱动的免疫抑制.
- 结合基因组向,电路中断和骨髓层重编程的协调治疗方法显示出控制GBM适应和改善患者结果的前景.
更多相关视频
10:08Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions
Published on: February 24, 2021
6.7K
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
3.9K
相关概念视频
DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
